NCT02078700 2025-06-25
Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.
Azienda USL Reggio Emilia - IRCCS
Phase 2 Completed
Clinical Trials
12 trialsNCT06159478 2023-12-13
Perfume
National Cancer Center, Japan
Phase 2 Recruiting
NCT02511223 2023-04-19
10
Sheba Medical Center
Phase 2 Completed
NCT02707159 2023-03-08
PACT-ACT-v6
Helse Stavanger HF
Phase 2 Completed
NCT02628860 2020-04-28
FCM
National Cancer Center, Korea
Phase 2 Completed
NCT04352023 2020-04-17
Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural
National Cancer Center, Korea
Phase 2 Unknown
NCT03002831 2020-04-02
Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer
Henan Cancer Hospital
Phase 2 Terminated
NCT03838029 2019-11-20
BC-PC
Assaf-Harofeh Medical Center
Phase 2 Unknown
NCT01587534 2015-04-15
Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP)
National Cancer Center, Korea
Phase 2 Completed
NCT01608841 2015-02-18
The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib
Taipei Veterans General Hospital, Taiwan
Phase 2 Unknown
NCT00636883 2014-01-22
GEMOX-T
National Guard Health Affairs
Phase 2 Terminated
NCT00658840 2012-04-03
Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma
National Cancer Center, Korea
Phase 2 Unknown